Foghorn Therapeutics Inc. (FHTX)
Last updated: 2026-10-24 09:40:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Foghorn Therapeutics Inc. (FHTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.00, with a market capitalization of $119.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.79 to $7.61. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$119.36M | |
$1.97 | |
$28.27 | |
$1.79 | |
$2.01 | |
437.10K | |
706.53K | |
-- | |
$7.61 | |
$1.79 | |
-- | |
-- |
Foghorn Therapeutics Inc. (FHTX) Latest Closing Stock Price
Foghorn Therapeutics Inc. (FHTX) last closed at $2.01 as of 2026-10-23 19:59:58, unchanged from the previous close of $2.01.
During the latest regular trading session, FHTX traded between $1.79 and $28.27, with a volume of 437.10K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Foghorn Therapeutics Inc. (FHTX) 7-Day Stock Price Change
Over the past seven days, Foghorn Therapeutics Inc. (FHTX) moved from $1.89 to $2.00, representing a gain of 6.03% ($0.11).
The stock traded between $1.80 and $2.10 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 562.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
FHTX 52-Week Price Position
Position in Range: 3.7%
FHTX is currently trading at $2.00, placing it 3.7% of the way from its 52-week low of $1.79 to its 52-week high of $7.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Foghorn Therapeutics Inc. (FHTX)?
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Foghorn Therapeutics Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 106 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Foghorn Therapeutics Inc. (FHTX) Stock on MEXC
Eligible investors can buy real shares of Foghorn Therapeutics Inc. (FHTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Foghorn Therapeutics Inc. (FHTX) stock price today?
2.Is FHTX stock going up or down today?
3.What is FHTX pre-market price?
4.What is FHTX after-hours price?
5.Is FHTX stock trading now?
6.Where does FHTX sit relative to its 52-week high and low?
7.What sector is Foghorn Therapeutics Inc. in?
8.What is Foghorn Therapeutics Inc.'s market capitalization and where is it listed?
9.How is FHTX valued in terms of P/E ratio and EPS?
10.Does Foghorn Therapeutics Inc. pay a dividend?
Explore More US Stocks
Search Stocks
FHTX Stock Calculator
Estimate the value between FHTX shares and USD.
FHTX Shares to USD
1.00 FHTX shares = 2.004 USD
Calculations are estimates based on the latest available price and are for reference only.


